Podocyte globotriaosylceramide (GL-3) content in male adult...

Podocyte globotriaosylceramide (GL-3) content in male adult patients with Fabry disease reduces following 6-12 months of treatment with migalastat

Najafian, Behzad, Sokolovskiy, Alexey, Barth, Jay, Castelli, Jeff, Williams, Hadis, Mauer, Michael
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
117
Language:
english
Journal:
Molecular Genetics and Metabolism
DOI:
10.1016/j.ymgme.2015.12.374
Date:
February, 2016
File:
PDF, 46 KB
english, 2016
Conversion to is in progress
Conversion to is failed